Since arterial oxygen tension decreases rapidly during apnoea (Weitzner, King and Ikezono, 1959) , neuromuscular blocking drugs should have a rapid onset of action when used to facilitate tracheal intubation. This is particularly important in infants and children, since, in these patients, Pa Ol may decrease more rapidly as a result of an increasing oxygen consumption, restlessness makes pre-oxygenation difficult, and the anatomy impedes intubation.
It has been observed recently that a small dose of a non-depolarizing neuromuscular blocking drug accelerates the onset of subsequent doses of the same drug. This has been reported in adults after divided doses of alcuronium (Hutton et al., 1983) , atracurium (Gergis et al., 1983; Nagashima, Nguyen et al., 1984) , pancuronium (Doherty et al., 1985) and vecuronium . Also, surgical relaxation was hastened when pancuronium was preceded by a small "priming" dose of metocurine (Nagashima, Stoll et al., 1984) .
Comparisons of the different behaviour of neuromuscular blockers in children and adults are difficult because of different methodology and anaesthesia. Nevertheless, it seems that the onset of action of non-depolarizing drugs is more rapid in children than in adults and this is said to be a consequence of more rapid drug delivery to the muscles in the very young. Despite the problems of different methodology, the more rapid onset of action has been demonstrated clearly using equipotent doses of vecuronium (Fisher and Miller, 1983) .
The present study was designed to complement a previous investigation in adults in which the same anaesthetic technique, dose of myoneural blocker and neuromuscular monitoring were used (Doherty et al., 1985) . The aim was to determine whether the onset of action and duration of effect of pancuronium were modified by its administration in divided doses to infants and children from 0 to 10 years of age.
interfere with neuromuscular transmission were included. Patients were studied in three groups of 20, according to age. Group 1 consisted of "infants" aged less than 12 months. Groups 2 and 3 consisted of "young children" aged from 1 to 3 yr and "older children" from 3 to 10 yr, respectively. Each group was subdivided randomly into two subgroups of 10 patients to receive pancuronium either as a single dose of 0.07 mg kg" 1 or as an initial (10%) dose of 0.007 mg kg" 1 3 min before the main dose of 0.063 mg kg"
1 . Premedication for all infants consisted of hyoscine 0.01 mg kg" 1 i.m. The children received pentobarbitone 3 mg kg" 1 rectally 2 h before surgery, followed by morphine 0.1 mg kg" 1 , and hyoscine 0.01 mg kg" 1 i.m. 1 h before surgery. Anaesthesia was induced with thiopentone 3-5 mg kg" 1 and fentanyl 2-3 ug kg" 1 i.v., and maintained with 70% nitrous oxide and 0.5-1 % halothane (inspired concentration) in oxygen. Endotracheal intubation was performed after the administration of the larger dose of pancuronium and ventilation was controlled to maintain normocarbia using the Bain system. Fresh gas flows were set according to the recommendations of Rose and Froese (1979) and, in most subjects, end-tidal PcOj was measured with a Hewlett-Packard capnograph to maintain PE'CO, at 4-5 kPa. Oesophageal temperature was measured and maintained between 35.5 and 37 °C. Neuromuscular transmission was monitored as described by Ali, Utting and Gray (1970) . The ulnar nerve was stimulated supramaximally using silver-silver chloride electrodes applied to the forearm. Trains of four square pulses of 0.2 ms duration at a frequency of 2 Hz were repeated every 12 s using a Grass S48 stimulator and an SIU5 isolation unit. The hand and forearm were immobilized in a splint and the force of contraction of the adductor pollicis was measured with a force displacement transducer (Grass FT03) and recorded using a pen-and-ink recorder (Grass Polygraph). Neuromuscular blockade was expressed as the height of the first twitch (Tl) as a percentage of pre-drug control values, and as the train-of-four ratio (T4/T1) (the height of the fourth twitch divided by the height of the first in each train). Pancuronium was not administered until the twitch recovery had stabilized, which usually occurred within 5-10 min.
The speed of onset of neuromuscular blockade was estimated as the time from the injection of the bolus or larger dose of pancuronium to 50 % and 90% depression of Tl, and the duration of action was assessed as the time from injection until Tl had recovered to 10%. Train-of-four ratios were measured at 10% decrements of Tl during the onset of blockade. These results in infants and children have been compared with those obtained in adults in a recent study using similar methodology (Doherty et al., 1985) .
Results are presented as mean values with standard error of the mean (SEM) as an index of dispersion. Where applicable, mean values were compared using one-way analysis of variance and unpaired Student's t test with Bonferoni's modification (Glantz, 1981) . Regression lines were constructed using the method of least squares and Kendall-Rank (KR) correlation coefficients were calculated.
RESULTS
At each age group the subgroups were comparable with respect to age and weight (table I) .
Onset and recovery of neuromuscular blockade
The onset times to 50 and 90 % block of Tl are shown in table II. Blockade developed more rapidly in the young and there were significant correlations between the patient's age and the times to 50 and 90% block (P < 0.001, KR). The onset tended to be more rapid when pancuronium was administered in divided doses, but this reached statistical significance only in the development of 50% block in the 3-10 yr group. (Doherty et al., 1985) . The durations of blockade were similar in all paediatric groups, and were not affected by giving pancuronium in divided doses.
Compared with previous adult data, the onset of neuromuscular blockade was more rapid in children and, although there was a tendency towards acceleration of the block when the drug was administered in divided doses, the effect was small and seldom achieved statistical significance. The duration of action was shorter in children than in adults, but did not demonstrate any difference between single and divided doses.
Pattern of neuromuscular blockade
The relationship between Tl depression and T4/T1 ratio was similar to that previously described in paediatric patients following bolus doses of pancuronium (Robbins et al., 1984) . Following the single dose of pancuronium, T4/T1 ratio tended to decrease in the older children. When Tl was decreased by 30% and 70%, the T4/T1 ratio was significantly less in the older children than in infants. No differences were observed in T4/T1 ratios between the groups who had received single or divided doses of pancuronium (table III) .
DISCUSSION
It is important to search for ways to accelerate the onset of action of non-depolarizing neuromuscular blockade because the use of suxamethonium to facilitate rapid intubation of the trachea is not always indicated or desirable. This study showed a decrease in the onset time for pancuronium in younger patients and, even in the older age group studied (3-10 yr), the onset was more rapid than in adults (Doherty et al., 1985) . However, the ideal neuromuscular blocker should have a much shorter onset of action in infants because their relatively greater oxygen consumption predisposes to arterial hypoxaemia (Kaplan and Graves, 1984) . Although pre-oxygenation can delay the onset of hypoxaemia in adults (Weitzner, King and Ikezono, 1959) , the protection afforded by such a manoeuvre in a young, unco-operative patient has not been evaluated.
Some acceleration in the onset of neuromuscular blockade was achieved by administering pancuronium in divided doses. However, the effect was small and much less than that seen previously in adults, although the magnitude and timing of the divided doses were similar (Doherty et al., 1985) . The small priming dose of pancuronium was chosen to avoid serious muscle weakness. Indeed, such doses of blockers seldom produce more than small decreases of neuromuscular activity without effect on ventilation (Ferguson and Bevan, 1981; Gal and Goldberg, 1981) . Similarly, the interval of 3 min between the priming and the main dose of pancuronium was selected because this is sufficient to avoid the problems associated with suxamethonium when tubocurarine is used for " pre-curarization" (Horrow and Lambert, 1984) . However, Foldes has recommended larger priming doses (pancuronium 0.015-0.02 mg kg" 1 ) followed, 6-8 min later, by the intubating dose . Priming doses of this magnitude can be expected to produce measurable weakness.
Several reasons can account for the acceleration of the onset of neuromuscular blockade when blockers are administered in divided doses. Paton and Waud (1967) have demonstrated that at least 70% of post-junctional receptors need to be occupied by neuromuscular blocking agents before neuromuscular transmission is measurably impaired. This concept, which they called the "margin of safety", has been confirmed by direct measurement of receptor occupation by blocking drugs (Caratsch et al., 1979) . Consequently, the small priming doses of neuromuscular blocker used in the present study produced occupation of receptors without paralysis. When a second paralysing dose of drug was given the remaining proportion of unoccupied receptors needed only to have a small number occupied to produce paralysis. Also, if calculations are made to predict the time taken for the concentration of blocking drug at the "effect" compartment (biophase) (Hull et al., 1978 ) to reach paralysing values, then this can account for an acceleration of about 0.2 min (Doherty et al., 1985) , which is compatible with the results in the present study.
When "priming" doses are given with a drug different from the "intubating" dose, additional acceleration may occur if the two agents potentiate each other (Lebowitz et al., 1980) perhaps by actions at different sites (Bowman, 1980) . Similarly, the presynaptic effect of pancuronium, as indicated by train-of-four fade, increases with time (Robbins et al., 1984) and this might be encouraged by pre-curarization. In the present study, the degree of fade was no different between single and divided doses. Consequently, there is no need to involve a separate mechanism of action.
The acceleration of onset in these paediatric patients was less than that seen in adults. In part, this was a reflection of the shorter onset time in children, so that the differences in absolute terms were less. Also, although attempts were made to standardize the conditions and to remove bias by randomization of patients, some differences remained. For example, the adult patients given divided doses were statistically younger than those receiving the bolus dose (44.9 ±2.9 v. 59.4 ±2.7 yr). Moreover, with changes in the order of only 20-30 % in children and with the degree of individual variation seen in the study, larger numbers are required before the null hypothesis can be rejected reliably (Glantz, 1981) . For example, it can be calculated that approximately 100 infants would be required to demonstrate a statistically significant shortening of onset with divided doses (Cohen, 1977) .
In conclusion, the onset of neuromuscular blockade in paediatric patients can be accelerated by administering pancuronium in divided doses. However, the difference is so small and is over-shadowed by the quicker onset in small children, that such a technique does not appear to convey any clinical advantage.
